IRAK4 anticorps (N-Term)
Aperçu rapide pour IRAK4 anticorps (N-Term) (ABIN2290936)
Antigène
Voir toutes IRAK4 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 32-60, N-Term
-
Réactivité croisée
- Humain
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu
-
Attributs du produit
- IRAK4, NT (IRAK4, Interleukin-1 receptor-associated kinase 4, Renal carcinoma antigen NY-REN-64)
-
Purification
- Purified by Protein A affinity chromatography.
-
Immunogène
- IRAK4 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 32-60 amino acids from the N-terminal region of human IRAK4.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- IRAK4 (Interleukin-1 Receptor-Associated Kinase 4 (IRAK4))
-
Autre désignation
- IRAK4
-
NCBI Accession
- NP_001107654, NP_057207
-
UniProt
- Q9NWZ3
-
Pathways
- Signalisation NF-kappaB, Signalisation TLR, Activation of Innate immune Response, Toll-Like Receptors Cascades
Antigène
-